Angel Miguel Rodriguez Rivera, MD, | |
Metro Pavia Health System, 1785 Carr 21, Las Lomas, San Juan, PR 00921-3399 | |
(787) 782-9999 | |
(509) 275-5604 |
Full Name | Angel Miguel Rodriguez Rivera |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 17 Years |
Location | Metro Pavia Health System, San Juan, Puerto Rico |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134419161 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 18873 (Puerto Rico) | Secondary |
2086X0206X | Surgery - Surgical Oncology | 18873 (Puerto Rico) | Primary |
Entity Name | Comprehensive Cancer Specialists |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1518364686 PECOS PAC ID: 8123343498 Enrollment ID: O20150207000280 |
News Archive
Obstructive sleep apnea (OSA) is associated with an increased risk of stroke in middle-aged and older adults, especially men, according to new results from new research supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. Overall, sleep apnea more than doubles the risk of stroke in men.
Novartis today announced new two-year results demonstrating sustained efficacy with Cosentyx (secukinumab) with an acceptable safety profile for the treatment of psoriasis patients. The data comes from the extension study of the pivotal Phase III FIXTURE and ERASURE trials.
Relapsing-Remitting Multiple Sclerosis (RRMS) patients have been anticipating the availability of new oral therapies being developed to treat their specific condition. Among the string of oral therapies entering the market is Novartis' Gilenya, which recently became available for use following receipt of FDA approval in late September. One-third of MS patients are aware the new oral agents are under development and there is substantial interest within this group to seek further information through physicians and other sources, according to new research by GfK HealthCare.
Findings from a new study led by scientists from the Florida campus of The Scripps Research Institute (TSRI) suggest a potent new therapeutic approach for a number of hard-to-treat breast cancers.
› Verified 3 days ago
Entity Name | Centro De Cancer De La Universidad |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215418751 PECOS PAC ID: 7113220385 Enrollment ID: O20210318001999 |
News Archive
Obstructive sleep apnea (OSA) is associated with an increased risk of stroke in middle-aged and older adults, especially men, according to new results from new research supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. Overall, sleep apnea more than doubles the risk of stroke in men.
Novartis today announced new two-year results demonstrating sustained efficacy with Cosentyx (secukinumab) with an acceptable safety profile for the treatment of psoriasis patients. The data comes from the extension study of the pivotal Phase III FIXTURE and ERASURE trials.
Relapsing-Remitting Multiple Sclerosis (RRMS) patients have been anticipating the availability of new oral therapies being developed to treat their specific condition. Among the string of oral therapies entering the market is Novartis' Gilenya, which recently became available for use following receipt of FDA approval in late September. One-third of MS patients are aware the new oral agents are under development and there is substantial interest within this group to seek further information through physicians and other sources, according to new research by GfK HealthCare.
Findings from a new study led by scientists from the Florida campus of The Scripps Research Institute (TSRI) suggest a potent new therapeutic approach for a number of hard-to-treat breast cancers.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Angel Miguel Rodriguez Rivera, MD, Po Box 11981, San Juan, PR 00922-1981 Ph: (787) 782-9999 | Angel Miguel Rodriguez Rivera, MD, Metro Pavia Health System, 1785 Carr 21, Las Lomas, San Juan, PR 00921-3399 Ph: (787) 782-9999 |
News Archive
Obstructive sleep apnea (OSA) is associated with an increased risk of stroke in middle-aged and older adults, especially men, according to new results from new research supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. Overall, sleep apnea more than doubles the risk of stroke in men.
Novartis today announced new two-year results demonstrating sustained efficacy with Cosentyx (secukinumab) with an acceptable safety profile for the treatment of psoriasis patients. The data comes from the extension study of the pivotal Phase III FIXTURE and ERASURE trials.
Relapsing-Remitting Multiple Sclerosis (RRMS) patients have been anticipating the availability of new oral therapies being developed to treat their specific condition. Among the string of oral therapies entering the market is Novartis' Gilenya, which recently became available for use following receipt of FDA approval in late September. One-third of MS patients are aware the new oral agents are under development and there is substantial interest within this group to seek further information through physicians and other sources, according to new research by GfK HealthCare.
Findings from a new study led by scientists from the Florida campus of The Scripps Research Institute (TSRI) suggest a potent new therapeutic approach for a number of hard-to-treat breast cancers.
› Verified 3 days ago
Mr. Roberto Luis Nevares, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 29 Washington St, Ste 203, San Juan, PR 00907 Phone: 787-722-6220 Fax: 787-722-4950 | |
Dr. Hiram Rafael Soler, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 735 Ave Ponce De Leon, Toeer Del Auxilio Suite 709, San Juan, PR 00917 Phone: 787-296-0540 Fax: 787-296-0544 | |
Francisco A. Batlle Batlle, M.D. F.A.C.S. Surgery Medicare: Accepting Medicare Assignments Practice Location: Torre San Francisco Suite 610, Avenida De Diego Num 369, San Juan, PR 00923 Phone: 787-771-4595 Fax: 787-771-0042 | |
Jose S. Reyes Torres, Surgery Medicare: Accepting Medicare Assignments Practice Location: 400 Ave Fd Roosevelt, Ste 202, San Juan, PR 00918 Phone: 787-621-3700 | |
Dr. Ivan Dominguez, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1462 Calle Prof Augusto Rodriguez, San Juan, PR 00909 Phone: 787-727-6060 | |
Dr. Rafael Pichardo, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1669 Calle Orinoco, Urb El Cerezal, San Juan, PR 00926 Phone: 787-777-3535 | |
Dr. Juan J Diaz Hernandez, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 29 Calle Washington, Ashford Medical Center Ste 505, San Juan, PR 00907 Phone: 787-596-7878 Fax: 787-721-2204 |